Investment manager Federation Asset Management and its co-investors have announced the sale of their indirect stake in George Clinical to Hillhouse Capital.
George Clinical is a medical research organisation that conducts large-scale clinical trials, epidemiological studies, health systems research, and population-based studies. It services the industry focused on treating chronic diseases such as heart disease, high blood pressure and diabetes.
Federation invested in George Clinical through its holding company, George Health. It retains an investment in George Health’s other divisions, including George Medicines and its prospective pipeline of pharmaceuticals.
“We are pleased to have sold George Clinical to Hillhouse Capital for a sizeable increase on our original investment,” said Federation’s CEO Cameron Brownjohn.
“We are also pleased with the depth and performance of Federation's broader portfolio and pipeline. Our investors are well exposed to sectors that benefit from the aging population mega trend which to us means strengths in healthcare, seniors financing and other white-collar service sectors.
“Our investors are also well exposed to a range of social infrastructure and energy transition infrastructure which we believe has strong growth potential," he added.